Private Label Peptide Eyelash Serum Manufacturer Low MOQ

Do I need FDA approval to sell a peptide eyelash serum in the US?

By Blake Mereby · Last reviewed October 5, 2026

No FDA pre-market approval is required to sell a peptide eyelash serum in the United States, provided the product is formulated and marketed as a cosmetic. Cosmetics do not require FDA approval before going to market under the Federal Food, Drug, and Cosmetic Act. However, this does not mean anything goes — the regulatory requirements are meaningful and recently expanded.

Under the Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022, all cosmetic manufacturers and certain brand owners (called 'responsible persons') must register their facilities with the FDA and submit product listings that include the product name, intended use, and full INCI ingredient list. Facility registration and product listing were required by December 29, 2023 for large companies and July 1, 2024 for small businesses. Confirm that any US manufacturer you work with is MoCRA-registered; this is now a baseline compliance requirement.

MoCRA also requires cosmetic companies to report serious adverse events (SAEs) to the FDA within 15 business days. Your contract manufacturer should advise you on building a complaint-handling and adverse event reporting process before you launch.

The critical line is the cosmetic/drug distinction. A peptide serum that claims to 'visibly enhance lash appearance' or 'condition lashes' is a cosmetic. A product that claims to 'grow new lashes,' 'treat lash loss,' or contains bimatoprost (a prescription prostaglandin analogue used in Latisse) is a drug. Drug claims on a cosmetically marketed product expose you to FDA warning letters, import alerts, and product seizure. Review every marketing claim — including influencer and social media posts — against this line.

For California sales, Prop 65 requires a warning if your product contains listed chemicals at levels above safe harbor thresholds. Some fragrance components and preservatives trigger Prop 65 — have your formulator review the INCI list.

If you plan to sell in the EU simultaneously, note that you will need a separate Product Information File (PIF), a Cosmetic Product Safety Report (CPSR) signed by a qualified EU safety assessor, and a Responsible Person (RP) entity based in the EU or UK. AJ Cosmo Labs connects you with regulatory consultants who can advise on dual-market compliance alongside manufacturer sourcing.

Read the full guide on Private Label Peptide Eyelash Serum Manufacturer Low MOQ →

More about Private Label Peptide Eyelash Serum Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app